RESPIRATORY TREATMENTS WITH AMNIO ALLOGRAFT
An inhaler device is used to deliver Amniotic Liquid Allograft directly to the respiratory system, as a topical treatment. This allows the nasal cavity, pharynx, larynx, bronchus and lungs to be treated.
The liquid allograft is specifically formulated to be suitable for delivery to the entire respiratory system for treatment of lung disorders including chronic obstructive pulmonary disorders (COPD), asthma, emphysema, bronchiectasis, chronic bronchitis, interstitial lung disease, alpha-1 antitrypsin emphysema, as well as for treatment of acute lung injuries.
Liquid allograft can be used to treat, or prevent one or more symptoms of a chronic lung disorder.
For many, one treatment is all that is needed to repair the injury. In some cases, additional treatments may be required depending on the severity and type of injury.
-Patient C.T. was diagnosed with COPD four years prior to the treatment. She had a persistent cough, shortness of breath, and poor skin color. After one treatment, C.T. appears to have much improved skin color, and is carrying out daily activities and exercising without shortness of breath. Furthermore, C.T. has had significant improvement with her cough and has not needed bronchodilation since her initial visit…which she attributes to the “miracle” of liquid allograft.
-Patient D.S. is a 14-year-old male with severe persistent asthma with acute exacerbations. He was diagnosed with asthma at the age of four. D.S. is a track athlete and he used an inhaler prior to and/or post track events.
Four days after the treatment, D.S reported that he had not had to use a rescue inhaler since the initial visit. Furthermore, he has entered running events without the need of any bronchodilation pre or post events.